Wednesday, August 13, 2016




  1. Approval of the Board of Directors Annual Report regarding the Company's Business Activity and the Company's Financial Administration in the Fiscal Year 2015.
  2. Ratification of the Company's Balance Sheet and Income statement in the Fiscal Year 2015 audited by the Public Accounting Firm Tanudiredja, Wibisana & Rekan.
  3. The Use of Net Income of the Fiscal Year 2015.
  4. Election of a Public Accountant Firm to audit the Company's Financial Statements in the Fiscal Year 2016, and determine the honorarium amount of the Public Accountant Firm.
SCPI - PT. Organon Pharma Indonesia Tbk

Rp 29.000

0 (0%)